Painful bladder syndrome, also known as interstitial cystitis, is a chronic urological condition characterized by persistent bladder pain and urinary symptoms with no obvious infectious cause. Its management requires specialized evaluation and personalized treatments.
The diagnosis of painful bladder syndrome or interstitial cystitis requires a specialized and personalized evaluation.
A comprehensive assessment is carried out, which may include:
An accurate diagnosis is essential for determining the most appropriate treatment and avoiding unnecessary or ineffective therapies.
Common cystitis or urinary tract infection is usually caused by bacteria and responds to antibiotic treatment. Interstitial cystitis or painful bladder syndrome is not caused by an infection; it is a chronic, autoimmune disease characterized by pelvic pain associated with bladder filling that is relieved by urination and is often associated with persistent urinary urgency and frequency.
Yes. It is often initially confused with a urinary tract infection, as both can cause pain, burning when urinating, urgency, and increased urinary frequency. However, in interstitial cystitis or painful bladder syndrome, urine cultures are usually negative, as it is not caused by bacteria. When symptoms persist despite receiving antibiotics, this possibility should be considered.
Yes. Because it can be confused with recurrent urinary tract infections or other pelvic disorders, some patients take months or even years to receive an accurate diagnosis. A specialized urology assessment allows for the study to be correctly guided and avoids unnecessary repeated treatments.
Painful bladder syndrome or interstitial cystitis is a chronic condition. This means that it can affect patients for years, although its progression varies greatly. Some people have mild and sporadic symptoms, while others may experience more persistent discomfort. With a proper diagnosis and personalized treatment, it is possible to significantly improve quality of life and reduce the intensity and frequency of symptoms.
Current management of stage T1 renal cell carcinoma in Spain: Results of a multicenter national registry.